NanoViricides, Inc.
(NYSE Amex Equities : NNVC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -1.09%165.320.7%$1060.19m
PFEPfizer Inc. 3.69%50.070.9%$942.34m
ABBVAbbVie, Inc. 0.35%142.571.9%$843.43m
MRKMerck & Co., Inc. 2.33%91.010.7%$812.67m
LLYEli Lilly & Co. 2.53%307.781.1%$790.95m
BMYBristol-Myers Squibb Co. 1.48%75.561.0%$658.77m
SIGASIGA Technologies, Inc. -0.16%24.750.0%$468.87m
AZNAstraZeneca Plc 3.08%66.641.0%$384.79m
GBTGlobal Blood Therapeutics, Inc. 0.27%66.755.6%$307.02m
ALNYAlnylam Pharmaceuticals, Inc. 1.94%233.858.2%$285.78m
GSKGSK Plc 0.84%36.030.3%$273.25m
HZNPHorizon Therapeutics Plc 0.55%67.475.4%$217.29m
KRTXKaruna Therapeutics, Inc. 6.17%277.420.0%$207.23m
CCXIChemoCentryx, Inc. 0.24%50.722.9%$191.50m
NVONovo Nordisk A/S -0.67%107.480.1%$184.93m

Company Profile

NanoViricides, Inc. is a development stage company, which engages in the development of nanomedicine drugs against viruses. It focuses on anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs. The company was founded by Anil R. Diwan on April 1, 2005 and is headquartered in Shelton, CT.